A Survival Benefit From Axillary Dissection: Was Halsted Correct?-Reference-Cited by-同舟云学术

A Survival Benefit From Axillary Dissection: Was Halsted Correct?

Published:1999-01 Issue:1 Volume:6 Page:17-18
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Morrow Monica

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10434-999-0017-4.pdf

Reference8 articles.

1. Fisher B. Laboratory and clinical research in breast cancer?a personal adventure: The David A Karnovsky Memorial Lecture. Cancer Res 1980;40:3863?74.

2. Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival?a Bayesian meta-analysis. Ann Surg Oncol 1999;6:109?16.

3. Hayward JL The Guy?s Hospital trials on breast conservation. In: Harris JR, Hellman S, Silen W, eds. Conservative management of breast cancer. New surgical and radiotherapeutic techniques. New York: JB Lippincott, 1983:77?90.

4. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312:674?81.

5. Morrow M, Foster RS. Staging of breast cancers. A new rationale for internal mammary node biopsy. Arch Surg 1981;116:748?51.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of axilla in breast cancer – The saga continues;The Breast;2015-08

2. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma;Journal of Clinical Investigation;2010-06-01

3. Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study;Breast Cancer Research and Treatment;2008-02-23

4. The number of negative nodes as a prognostic factor in breast cancer: A difficult concept to defend;European Journal of Surgical Oncology (EJSO);2008-01

5. Is there any Prognostically Different Subgroup among Patients with Stage IIIC (Any TN3M0) Breast Carcinoma?;Annals of Surgical Oncology;2007-10-03